Article Sidebar
Published:
Apr 14, 2025Keywords:
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
JIEPH content licensing: Articles published in JIEPH are distributed under the terms of the Creative Commons By Attribution 4.0 International License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The author(s) keep(s) the copyright to his/their article if and when the article is accepted for publication. The copyright covers the exclusive and unlimited rights to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form); it also covers translation rights for all languages and countries.
Main Article Content
COVID-19 vaccine acceptance and associated factors among pregnant women attending antenatal care in public health facilities of Addis Ababa, Ethiopia, 2022
Abstract
Introduction: Coronavirus disease 2019 (COVID-19) is a communicable disease that produces severe morbidity and mortality. Pregnant mothers are at higher risk of this viral infection, with great morbidity and mortality. However, vaccine acceptance among pregnant women were not known in the study area. We assessed COVID-19 vaccine acceptance and associated factors among pregnant women attending antenatal care in public health facilities of Addis Ababa city administrations, Ethiopia, 2022.
Methods: Institutional-based cross-sectional design was conducted among 348 randomly selected pregnant women attending antenatal care visits in public health facilities of Addis Ababa using an interviewer-administered questionnaire. Multivariable logistic regression analysis was to identify factors associated with vaccine acceptance. Variables with 95% confidence interval that does not include 1 and P-value < 0.05 were identified as statistically significant.
Results: The prevalence of COVID-19 vaccine acceptance among the participants was 58.0% (95%CI: 52.7-63.3). Vaccine acceptability was significantly associated with those assuming vaccine decreases severe symptoms, (aOR=2.4, 95%CI:1.1- 5.1), assuming vaccine is an effective treatment for active infection (aOR=2.4, 95%CI: 1.14-5.0), being allergic to medication (aOR=0.2, 95%CI:0.13-0.58), young age (aOR=0.1, 95%CI: 0.05-0.2), and perceived effects of the vaccine on the fetus (aOR=0.2, 95%CI:0.05-0.82).
Conclusion: More than half of the pregnant women in the studied public health facilities would accept to receive the COVID-19 vaccine. The main factors associated with accepting COVID-19 vaccine were assumptions that the vaccine was an effective treatment for active infection or that it decreases symptomatic COVID-19 infection, while being allergic to medication, young age and perceived impacts of the vaccine on the fetus were associated with not accepting the vaccine. Therefore, it is important to raise awareness about the benefits of the vaccine and dismiss the taboos about the vaccine to increase its acceptability.
